Autologous bone marrow transplantation following high-dose chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of current literature
- 1 October 1984
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (10), 1233-1238
- https://doi.org/10.1016/0277-5379(84)90252-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer a phase I-II studyCancer, 1983
- High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinomaCancer, 1983
- High-dose methotrexate in small cell lung cancer: Lack of efficacy in preventing CNS relapseCancer, 1983
- Small cell carcinoma of the lungCancer Treatment Reviews, 1982
- High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancerThe American Journal of Medicine, 1981
- 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced Pulmonary FibrosisNeurosurgery, 1980
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- Prediction of BCNU Pulmonary Toxicity in Patients with Malignant GliomasNew England Journal of Medicine, 1980
- High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumorsCancer, 1980
- Progrediente Lungenfibrose unter Kombinationstherapie mit BCNUBlut: Zeitschrift für die Gesamte Blutforschung, 1978